Stocks

The table gives an overview of all stocks, alphabetically sorted.
 X Financial American Depositary Shares, each representing tw XYF Nov 30, 2020 2.50 -9.09   
 X4 Pharmaceuticals, Inc. XFOR Nov 30, 2020 6.60 -2.94   
 XAI Octagon Floating Rate & Alternative Income Term Trust XFLT Nov 30, 2020 7.40 +0.14   
 XBiotech Inc XBIT Nov 30, 2020 19.06 -1.70   
 Xcel Brands, Inc XELB Nov 30, 2020 0.98 -12.51   
 Xcel Energy Inc. XEL Nov 30, 2020 67.36 -0.38   
 Xencor, Inc. XNCR Nov 30, 2020 42.32 -1.01   
 Xenetic Biosciences, Inc. XBIO Nov 30, 2020 1.14 +12.87   
 Xenia Hotels & Resorts, Inc. XHR Nov 30, 2020 14.09 -4.54   
 Xenon Pharmaceuticals Inc. - XENE Nov 30, 2020 11.89 +4.30   
 Xeris Pharmaceuticals, Inc. XERS Nov 30, 2020 4.36 -3.75   
 Xerox Holdings Corporation XRX Nov 30, 2020 21.89 -5.73   
 Xilinx, Inc. XLNX Nov 30, 2020 145.55 +5.86   
 Xinyuan Real Estate Co Ltd American Depositary Shares XIN Nov 30, 2020 2.54 -6.62   
 XOMA Corporation XOMA Nov 30, 2020 33.11 +3.31   
 XP Inc. - Class A Common Stock XP Nov 30, 2020 41.01 -1.56   
 XPEL, Inc. XPEL Nov 30, 2020 37.88 -1.84   
 XPeng Inc. American depositary shares, each representing two XPEV Nov 30, 2020 58.76 0.00   
 Xperi Holding Corporation XPER Nov 30, 2020 19.08 -1.34   
 XPO Logistics Inc XPO Nov 30, 2020 106.68 +0.81   
 XpresSpa Group, Inc. XSPA Nov 30, 2020 1.64 -2.38   
 Xtant Medical Holdings Inc XTNT Nov 30, 2020 1.20 -3.23   
 XTL Biopharmaceuticals Ltd. - American Depositary Shares XTLB Nov 30, 2020 2.46 -1.97   
 Xunlei Limited - American Depositary Shares XNET Nov 30, 2020 2.87 -3.37   
 Xylem Inc. XYL Nov 30, 2020 95.97 -1.20   
 Y-mAbs Therapeutics, Inc. YMAB Nov 30, 2020 50.87 +5.56   
 Yalla Group Limited YALA Nov 30, 2020 15.41 0.00   
 Yamana Gold Inc. AUY Nov 30, 2020 5.22 +2.15   
 Yandex N.V. - Class A Ordinary Shares YNDX Nov 30, 2020 68.96 +2.63   
 Yatra Online, Inc. - Ordinary Shares YTRA Nov 30, 2020 1.69 -1.17   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now